You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
{{ message }}
This repository has been archived by the owner on May 7, 2019. It is now read-only.
Sorry, I did not notice this question before, so I'm only replying now.
Sarek was at the beginning designed to analyse tumor/normal pairs (and additional relapses), but we realised that it could work with just normal samples as well. Sarek was at the beginning a WGS analysis project, and we're still adding possibilities for analysing WES and targeted sequencing.
This nf-core/exoseq pipeline was designed since the beginning to analyse Exome data, so it's definitively less complicated, and it obviously doesn't work on WGS.
I also think that the development is on hold at the moment.
What is the difference between this and Sarek pipeline?
The text was updated successfully, but these errors were encountered: